April 18, 2024 | New York Law Journal
Suboxone: Profits Over People; Developments in Purdue Pharma BankruptcyThis issue of the Mass Torts Update addresses the United Judicial Panel on Multidistrict Litigation ordering the consolidation of Suboxone dental injury lawsuits as centralized in the the Northern District of Ohio. It goes on to provide an update on Purdue Pharma's Chapter 11 bankruptcy case.
By Edward E. Neiger, Alexandra Robertson and Gregory Lawrence
5 minute read
March 08, 2024 | New York Law Journal
Understanding Rule 702 and the 'Daubert' Standard; Related Updates in the Tylenol and Paraquat MDLsThis article discusses how, for multidistrict litigation (MDL) to move forward to trials, we must understand 'Daubert', Rule 702 and the role of the judge in determining the admissibility of expert testimony. It goes on to highlight recent updates in related Tylenol and Paraquat MDL cases.
By Edward E. Neiger, Alexandra Robertson and Gregory Lawrence
6 minute read
October 27, 2022 | New York Law Journal
Developments in Camp Lejeune, Mallinckrodt and Boy Scouts CasesOn Aug. 10, 2022, President Biden signed the Camp Lejeune Justice Act of 2022 which provides a powerful statutory cause of action for individuals who experienced harm as a result of exposure to contaminated water at Camp Lejeune in North Carolina; the Mallinckrodt trustee is currently accepting and processing claims for damages from creditors who were injured by Mallinckrodt's opioids; and the bankruptcy court ultimately confirmed BSA's plan of reorganization on Sept. 8, 2022.
By Edward E. Neiger, Alexandra Robertson and David Stern
6 minute read